(Q44815260)

6 December 2017

Rate of serious infections in Behçet's disease patients receiving biologic therapies: a prospective observational study (English)

1 reference

6 December 2017

0 references

Chiara Baldini

7

0 references

Stefano Bombardieri

9

object named as

Stefano Bombardieri

1 reference

6 December 2017

Rosaria Talarico

1

1 reference

6 December 2017

Laura Bazzichi

2

1 reference

6 December 2017

Anna d'Ascanio

3

1 reference

6 December 2017

Claudia Ferrari

4

1 reference

6 December 2017

Elena Elefante

5

1 reference

6 December 2017

Chiara Tani

6

1 reference

6 December 2017

Marta Mosca

8

1 reference

6 December 2017

26 May 2013

1 reference

6 December 2017

Clinical Rheumatology

1 reference

6 December 2017

32

1 reference

6 December 2017

10

1 reference

6 December 2017

1547-1548

1 reference

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

6 December 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2290-7

Infliximab for patients with neuro-Behcet's disease: case series and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2290-7

Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2290-7

Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2290-7

Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: a retrospective analysis of 49 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2290-7

Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2290-7

Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature.

21 January 2018

1 reference

12 December 2020

Behçet's syndrome is not so rare: why do we need to know?

1 reference

12 December 2020

Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis

1 reference

12 December 2020

Behçet's disease: features of neurological involvement in a dedicated centre in Italy.

1 reference

12 December 2020

10.1007/S10067-013-2290-7

Identifiers

DOI

1 reference

6 December 2017

1 reference